1. Home
  2. AVDL vs HFWA Comparison

AVDL vs HFWA Comparison

Compare AVDL & HFWA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVDL
  • HFWA
  • Stock Information
  • Founded
  • AVDL 2015
  • HFWA 1927
  • Country
  • AVDL Ireland
  • HFWA United States
  • Employees
  • AVDL N/A
  • HFWA N/A
  • Industry
  • AVDL Biotechnology: Pharmaceutical Preparations
  • HFWA Banks
  • Sector
  • AVDL Health Care
  • HFWA Finance
  • Exchange
  • AVDL Nasdaq
  • HFWA Nasdaq
  • Market Cap
  • AVDL 784.6M
  • HFWA 843.8M
  • IPO Year
  • AVDL 1996
  • HFWA N/A
  • Fundamental
  • Price
  • AVDL $8.03
  • HFWA $21.85
  • Analyst Decision
  • AVDL Strong Buy
  • HFWA Hold
  • Analyst Count
  • AVDL 7
  • HFWA 3
  • Target Price
  • AVDL $18.86
  • HFWA $25.67
  • AVG Volume (30 Days)
  • AVDL 1.1M
  • HFWA 343.0K
  • Earning Date
  • AVDL 05-07-2025
  • HFWA 04-24-2025
  • Dividend Yield
  • AVDL N/A
  • HFWA 4.40%
  • EPS Growth
  • AVDL N/A
  • HFWA N/A
  • EPS
  • AVDL N/A
  • HFWA 1.24
  • Revenue
  • AVDL $169,117,000.00
  • HFWA $210,555,000.00
  • Revenue This Year
  • AVDL $50.53
  • HFWA $24.50
  • Revenue Next Year
  • AVDL $32.33
  • HFWA $6.69
  • P/E Ratio
  • AVDL N/A
  • HFWA $17.62
  • Revenue Growth
  • AVDL 504.79
  • HFWA N/A
  • 52 Week Low
  • AVDL $6.38
  • HFWA $16.55
  • 52 Week High
  • AVDL $19.09
  • HFWA $27.58
  • Technical
  • Relative Strength Index (RSI)
  • AVDL 54.47
  • HFWA 40.69
  • Support Level
  • AVDL $6.38
  • HFWA $20.56
  • Resistance Level
  • AVDL $8.22
  • HFWA $22.10
  • Average True Range (ATR)
  • AVDL 0.48
  • HFWA 1.17
  • MACD
  • AVDL 0.11
  • HFWA -0.06
  • Stochastic Oscillator
  • AVDL 89.67
  • HFWA 40.36

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

About HFWA Heritage Financial Corporation

Heritage Financial Corp is a bank holding company. The company through its subsidiary provides commercial lending and deposit relationships with small businesses and their owners in its market areas and attracts deposits from the general public. It accepts various deposit products, such as noninterest demand accounts, money market accounts, savings accounts, and certificates of deposit. Besides, the Bank also makes real estate construction loans, land development loans, and consumer loans, and originates first mortgage loans on residential properties mainly located in its market area. Geographically, all the business activity functions through the region of the United States.

Share on Social Networks: